Karyopharm Therapeutics Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
KPTI on Nasdaq
Industry
Pharmaceutical Preparations
Location
85 Wells Avenue, Second Floor, Newton, MA

Insiders trading volume in the past year

Karyopharm Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard A. Paulson President and CEO, Director $2.43M -$162K -6.27% Nov 5, 2024
Sharon Shacham Chief Scientific Officer $1.37M Mar 29, 2022
Michael Kauffman Director $1.32M Feb 28, 2022
Reshma Rangwala EVP & Chief Medical Officer $821K -$33.4K -3.91% Apr 22, 2024
Sohanya Cheng EVP & Chief Commercial Officer $764K -$35.6K -4.45% Sep 4, 2024
Michael Mason EVP, CFO & Treasurer $761K -$55.6K -6.81% Sep 4, 2024
Stuart Poulton EVP, Chief Development Officer $742K -$37.3K -4.79% Jul 30, 2024
Michael Mano SVP, General Counsel&Secretary $531K -$27K -4.84% Sep 4, 2024
Ran Frenkel EVP, Chief Dev. Officer $138K Feb 28, 2022
Kristin Abate Chief Accounting Officer $128K Nov 6, 2024
Jatin Shah EVP, Chief Medical Officer $106K Feb 17, 2022
Stephen Mitchener SVP, Chief Business Officer $105K Feb 28, 2023
Garen Bohlin Director $37K May 29, 2024
Deepika Pakianathan Director $0 -$1.67M -100% Jun 5, 2024
Christy J. Oliger Director May 29, 2024
Chen Schor Director May 29, 2024
Zhen Su Director May 29, 2024
Mansoor Raza Mirza Director May 29, 2024
Greene Barry E Director May 29, 2024
Peter Honig Director May 24, 2023
Mikael Dolsten Director May 21, 2021

Recent Insider Transactions by Companies or Individuals for Karyopharm Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.